Simple-Virilizing Congenital adrenal hyperplasia sustained by five mutations on the CYP21A2 gene

被引:0
|
作者
Agrimonti, Gloria [1 ]
Spaggiari, Giorgia [2 ,3 ]
Menabo, Soara [4 ]
Vezzani, Silvia [5 ]
Magnani, Elisa [5 ]
Frasoldati, Andrea [5 ]
Granata, Antonio R. M. [2 ,3 ]
Santi, Daniele [1 ,2 ,3 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy
[2] Azienda Osped Univ Modena, Dept Med Specialties, Unit Endocrinol, Modena, Italy
[3] Azienda Osped Univ Modena, Dept Med Specialties, Unit Androl & Sexual Med, Unit Endocrinol, Modena, Italy
[4] IRCCS Azienda Osped Univ Bologna, Med Genet Unit, Bologna, Italy
[5] Azienda USL IRCCS Reggio Emilia, Endocrinol Unit, Reggio Emilia, Italy
来源
BIOMEDICAL RESEARCH AND THERAPY | 2024年 / 11卷 / 07期
关键词
Congenital adrenal hyperplasia; Testosterone; 21-hydroxylase gene; STEROID 21-HYDROXYLASE DEFICIENCY; GENOTYPE-PHENOTYPE CORRELATION; VARIANTS;
D O I
10.15419/bmrat.v11i7.905
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Classical congenital adrenal hyperplasia is a genetic disorder characterized by defects in the steroidogenesis cascade, mainly due to 21-hydroxylase enzyme deficiency. The phenotype can vary from the most severe salt-wasting syndrome to the less severe simple-virilizing form. The genotype-phenotype correlation is complex, and it is expected that the higher the number of mutations detected, the worse the phenotype would be. Moreover, when more than one mutation occurs in the same patient, the phenotype should be the result of the most severe mutation detected. Case Presentation: This is the case of a 49-year-old Caucasian man with simple virilizing congenital adrenal hyperplasia, diagnosed at two years of age due to neonatal presentation of ambiguous genitalia. The karyotype was 46, XX, the phenotype was male, and hormonal evaluations highlighted cortisol deficiency, which required cortisone acetate replacement therapy. Gonads were removed during infancy, surgical interventions were performed to align physical attributes with his male gender identity, and the patient underwent testosterone replacement therapy. During adulthood, while compensation for cortisone acetate was reached, managing testosterone therapy proved to be challenging, achieved after the introduction of a low dose of dexamethasone (0.125 mg daily) and testosterone gel 2% 30 mg daily. Genetic analysis unraveled five different heterozygous pathogenic variants on the CYP21A2 gene. One mutation was detected on the maternal allele, while the remaining four were found on the second allele. Three of these mutations were proven to be pathognomonic for the salt-wasting form. Conclusion:This case underscored the intricate and heterogeneous correlation between genotype and phenotype in simple-virilizing congenital adrenal hyperplasia, illustrated by a patient with a rare occurrence of five distinct pathogenic mutations on the CYP21A2 gene. Although three of the five mutations detected are related to the salt-wasting congenital adrenal hyperplasia, only a simple-virilizing form was detected here. Moreover, although it is supposed that the higher the number of mutations detected, the worse the phenotype should be, here we described a simple-virilizing form in a patient with five mutations on the CYP21A2 gene.
引用
收藏
页码:6583 / 6591
页数:9
相关论文
共 50 条
  • [21] CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
    Umana-Calderon, Andres
    Jose Acuna-Navas, Maria
    Alvarado, Danny
    Jimenez, Mildred
    Cavallo-Aita, Fred
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2021, 27
  • [22] Molecular analysis of CYP21A2 mutations for congenital adrenal hyperplasia in Japan.
    Usui, T
    Nishisho, K
    Kaji, M
    Nagata, D
    Sato, N
    Tagami, T
    Seta, K
    Shimatsu, A
    Naruse, M
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 1115 - 1119
  • [23] Functional characterization and molecular modeling of the mutations in CYP21A2 gene from patients with Congenital Adrenal Hyperplasia
    Khajuria, Ragini
    Walia, Rama
    Bhansali, Anil
    Prasad, Rajendra
    BIOCHIMIE, 2018, 149 : 115 - 121
  • [24] CYP21A2 mutations in congenital adrenal hyperplasia due to 21 hydroxylase deficiency in Turkish population
    Cilingir, O.
    Simsek, E.
    Aras, B. Durak
    Erzurumluoglu, E.
    Binay, C.
    Temena, M. A.
    Kocagil, S.
    Artan, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 77 - 78
  • [25] Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene
    Rabbani, Bahareh
    Mahdieh, Nejat
    Ashtiani, Mohammad-Taghi Haghi
    Akbari, Mohammad-Taghi
    Rabbani, Ali
    IRANIAN JOURNAL OF PEDIATRICS, 2011, 21 (02) : 139 - 150
  • [26] Frequency of CYP21A2 gene in a pediatric Portuguese population with congenital adrenal hyperplasia
    Rosmaninho-Salgado, J.
    Serra Caetano, J.
    Carvalho, R.
    Dinis, I.
    Ramos, L.
    Ramos, F.
    Carvalho, A.
    Vasquez, A.
    Sa
    Maia, S.
    Sousa, S.
    Saraiva, J.
    Mirante, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 887 - 887
  • [27] Congenital adrenal hyperplasia (CAH) due to a small indel in the CYP21A2 gene
    Kuperman, H.
    Bachega, T.
    Billerbeck, A.
    Damiani, D.
    HORMONE RESEARCH, 2007, 68 : 16 - 16
  • [28] CYP21A2 Gene Mutation in South Indian Children with Congenital Adrenal Hyperplasia
    Ganesh, Ramaswamy
    Suresh, Natarajan
    Janakiraman, Lalitha
    Ravikumar, Karnam
    INDIAN PEDIATRICS, 2015, 52 (08) : 710 - 711
  • [29] Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia
    Haider, Shozeb
    Islam, Barira
    D'Atri, Valentina
    Sgobba, Miriam
    Poojari, Chetan
    Sun, Li
    Yuen, Tony
    Zaidi, Mone
    New, Maria I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (07) : 2605 - 2610
  • [30] Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia
    Tsai, Li-Ping
    Cheng, Ching-Feng
    Hsieh, Jo-Ping
    Teng, Ming-Sheng
    Lee, Hsien-Hsiung
    CLINICA CHIMICA ACTA, 2009, 410 (1-2) : 48 - 53